Oct 22 (Reuters) - Cardno Ltd (CDD) : CARDNO CURRENTLY ANTICIPATES FY21 EBITDA (PRE AASB 16 BASIS) TO BE IN RANGE OF $40 MILLION TO $45 MILLION
PTX This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution